Expand The Use And Value Of Your Product Over Time

In the final episode of the De-risking Drug Development series, the focus shifts to post-launch market development and strategies for maximizing long-term product value. Experts delve into lifecycle optimization, emphasizing the need for early planning—starting as early as Phase 1 or 2—to ensure sustained market growth and global expansion opportunities.

The discussion introduces a broader perspective on the Target Product Profile (TPP), redefining it as “target product potential.” This forward-thinking approach encourages biotech companies to envision future possibilities beyond initial approval, exploring new indications, markets, and patient populations to extend product impact and profitability. Each expert offers essential advice on overlooked strategies biotech developers should consider at this stage, highlighting how early, global, and adaptive planning can transform a product’s post-launch trajectory and unlock its full market potential.